Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom P Freeman

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Psychological Medicine|September 5, 2018
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?H Valerie Curran, Chandni Hindocha, Celia J A Morgan, et al.
BMC Public Health|July 3, 2025
What is the effect of presenting evidence of the mental vs physical health benefits of quitting smoking on motivation to stop smoking? An online randomised controlled experimentKatherine Sawyer, Adham Hanafi, Tom P Freeman, et al.
Addiction (Abingdon, England)|November 7, 2020
Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysisTom P Freeman, Sam Craft, Jack Wilson, et al.
The American Journal of Psychiatry|November 29, 2023
The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS)Jack Wilson, Katherine L Mills, Matthew Sunderland, et al.
International Journal of Mental Health and Addiction|June 26, 2023
Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin DependenceJack Wilson, Katherine L Mills, Matthew Sunderland, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2020
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trialsEdward Chesney, Dominic Oliver, Alastair Green, et al.
Addiction (Abingdon, England)|June 5, 2014
Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?Tom P Freeman, Celia J A Morgan, Chandni Hindocha, et al.
Addiction (Abingdon, England)|January 20, 2012
Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'Tom P Freeman, Celia J A Morgan, James Vaughn-Jones, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 24, 2019
New trends in cannabis potency in USA and Europe during the last decade (2008-2017)Suman Chandra, Mohamed M Radwan, Chandrani G Majumdar, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 25, 2019
Correction to: New trends in cannabis potency in USA and Europe during the last decade (2008-2017)Suman Chandra, Mohamed M Radwan, Chandrani G Majumdar, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Psychological Medicine|September 5, 2018
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?H Valerie Curran, Chandni Hindocha, Celia J A Morgan, et al.
BMC Public Health|July 3, 2025
What is the effect of presenting evidence of the mental vs physical health benefits of quitting smoking on motivation to stop smoking? An online randomised controlled experimentKatherine Sawyer, Adham Hanafi, Tom P Freeman, et al.
Addiction (Abingdon, England)|November 7, 2020
Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysisTom P Freeman, Sam Craft, Jack Wilson, et al.
The American Journal of Psychiatry|November 29, 2023
The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS)Jack Wilson, Katherine L Mills, Matthew Sunderland, et al.
International Journal of Mental Health and Addiction|June 26, 2023
Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin DependenceJack Wilson, Katherine L Mills, Matthew Sunderland, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2020
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trialsEdward Chesney, Dominic Oliver, Alastair Green, et al.
Addiction (Abingdon, England)|June 5, 2014
Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?Tom P Freeman, Celia J A Morgan, Chandni Hindocha, et al.
Addiction (Abingdon, England)|January 20, 2012
Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'Tom P Freeman, Celia J A Morgan, James Vaughn-Jones, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 24, 2019
New trends in cannabis potency in USA and Europe during the last decade (2008-2017)Suman Chandra, Mohamed M Radwan, Chandrani G Majumdar, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 25, 2019
Correction to: New trends in cannabis potency in USA and Europe during the last decade (2008-2017)Suman Chandra, Mohamed M Radwan, Chandrani G Majumdar, et al.
Pageof 20